Viewing Study NCT03284502

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2026-04-25 @ 1:18 AM
Study NCT ID: NCT03284502
Status: UNKNOWN
Last Update Posted: 2023-08-01
First Post: 2017-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors
Sponsor: Hanmi Pharmaceutical Company Limited
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Solid Tumor View
None Metastatic Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Belvarafenib View
None HM95573 View
None GDC-5573 View
None RG6185 View
None Cobimetinib View
None Cetuximab View